Mimicking Helical Antibacterial Peptides with Nonpeptidic Folding Oligomers

Chemistry and Biology

Volumn 13, Issue 5, 2006, Pages 531-538

  Violette, Aude ^a   Fournel, Sylvie ^a   Lamour, Karen ^a   Chaloin, Olivier ^a   Frisch, Benoit ^b   Briand, Jean Paul ^a   Monteil, Henri ^b   Guichard, Gilles ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

CHEMBIO; MICROBIO

Indexed keywords

BACTERIA (MICROORGANISMS); MAMMALIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; POSIBACTERIA;

ANTIINFECTIVE AGENT; BIOPOLYMER; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; CIRCULAR DICHROISM; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR MIMICRY; PENICILLIN RESISTANCE; PROTEIN SECONDARY STRUCTURE; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BIOPOLYMERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; METHICILLIN RESISTANCE; MOLECULAR MIMICRY; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAPHYLOCOCCUS AUREUS;

EID: 33746888689     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2006.03.009     Document Type: Article

References (39)

1. Habermann E. Bee and wasp venoms. Science 177 (1972) 314-322
2. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 84 (1987) 5449-5453
3. Steiner H., Hultmark D., Engstrom A., Bennich H., and Boman H.G. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292 (1981) 246-248
4. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
5. Ge Y., MacDonald D.L., Holroyd K.J., Thornsberry C., Wexler H., and Zasloff M. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43 (1999) 782-788
6. Dartois V., Sanchez-Quesada J., Cabezas E., Chi E., Dubbelde C., Dunn C., Granja J., Gritzen C., Weinberger D., Ghadiri M.R., et al. Systemic antibacterial activity of novel synthetic cyclic peptides. Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob. Agents Chemother. 49 (2005) 3302-3310
7. Hancock R.E., and Chapple D.S. Peptide antibiotics. Antimicrob. Agents Chemother. 43 (1999) 1317-1323
8. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 66 (2002) 236-248
9. McDonald D.L., Beyermann M., and Bienert M. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial activity of amphipathic helical peptides. FEBS Lett. 403 (1997) 208-212
10. Dathe M., and Wieprecht T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1462 (1999) 71-87
11. Guichard G. β-Peptides, γ-peptides and isosteric backbones: new scaffolds with controlled shapes for mimicking protein secondary structure elements. In: Nielsen P.E. (Ed). Pseudopeptides in Drug Development (2004), Wiley-VCH Verlag, Weinheim, Germany 33-120
12. Seebach D., Beck A.K., and Bierbaum D.J. The world of β- and γ-peptides comprised of homologated proteinogenic amino acids and other components. Chem. Biodiv. 1 (2004) 1111-1239
13. Cheng R.P., Gellman S.H., and DeGrado W.F. β-Peptides: from structure to function. Chem. Rev. 101 (2001) 3219-3232
14. Porter E.A., Wang X., Lee H.S., Weisblum B., and Gellman S.H. Non-haemolytic beta-amino-acid oligomers. Nature 404 (2000) 565 Erratum: Nature 405(6784), 298
15. Porter E.A., Weisblum B., and Gellman S.H. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. J. Am. Chem. Soc. 124 (2002) 7324-7330
16. Raguse T.L., Porter E.A., Weisblum B., and Gellman S.H. Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency. J. Am. Chem. Soc. 124 (2002) 12774-12785
17. Liu D., and DeGrado W.F. De novo design, synthesis, and characterization of antimicrobial β-peptides. J. Am. Chem. Soc. 123 (2001) 7553-7559
18. Arvidsson P.I., Ryder N.S., Weiss H.M., Gross G., Kretz O., Woessner R., and Seebach D. Antibiotic and hemolytic activity of a β2/β3 peptide capable of folding into a 12/10-helical secondary structure. ChemBioChem 4 (2003) 1345-1347
19. Patch J.A., and Barron A.E. Helical peptoid mimics of magainin-2 amide. J. Am. Chem. Soc. 125 (2003) 12092-12093
20. Semetey V., Rognan D., Hemmerlin C., Graff R., Briand J.-P., Marraud M., and Guichard G. Stable helical secondary structure in short chain N,N′-linked oligoureas bearing proteinogenic side chains. Angew. Chem. Int. Ed. Engl. 41 (2002) 1893-1895
21. Hemmerlin C., Marraud M., Rognan D., Graff R., Semetey V., Briand J.-P., and Guichard G. Helix forming oligoureas: temperature-dependent NMR, structure determination and circular dichroism of a nonomer with functionalised side chain. Helv. Chim. Acta 85 (2002) 3692-3711
22. Violette A., Averlant-Petit M.C., Semetey V., Hemmerlin C., Casimir R., Graff R., Marraud M., Briand J.-P., Rognan D., and Guichard G. N,N′-linked oligoureas as foldamers: chain length requirements for helix formation in protic solvent investigated by circular dichroism, NMR spectroscopy and molecular dynamics. J. Am. Chem. Soc. 127 (2005) 2156-2164
23. Guichard G., Semetey V., Rodriguez M., and Briand J.-P. Solid phase synthesis of oligoureas using O-succinimidyl-(9H-fluoren-9-ylmethoxycarbonylamino)-ethyl carbamate derivatives. Tetrahedron Lett. 41 (2000) 1553-1557
24. Guichard G., Semetey V., Didierjean C., Aubry A., Briand J.-P., and Rodriguez M. An effective preparation of O-succinimidyl-2-(tert-butoxycarbonylamino)-ethylcarbamate derivatives from β-amino-acids. Application to the synthesis of urea-containing pseudopeptides and oligoureas. J. Org. Chem. 64 (1999) 8702-8705
25. 3-residues with side-chain branching adjacent to the β-carbon atom. Helv. Chim. Acta 85 (2002) 4154-4164
26. 3-peptides in water. J. Am. Chem. Soc. 127 (2005) 167-178
27. Martinek T.A., and Fülöp F. Side-chain control of β-peptide secondary structures. Eur. J. Biochem. (Tokyo) 270 (2003) 3657-3666
28. Yau W.-M., Wimley W.C., Gawrisch K., and White S.H. The preference of tryptophan for membrane interfaces. Biochemistry 37 (1998) 14713-14718
29. Selsted M.E., Novotny M.J., Morris W.L., Tang Y.Q., Smith W., and Cullor J.S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 267 (1992) 4292-4295
30. Vogel H.J., Schibli D.J., Jing W., Lohmeier-Vogel E.M., Epand R.F., and Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 80 (2002) 49-63
31. Deslouches B., Phadke S.M., Lazarevic V., Cascio M., Islam K., Montelaro R.C., and Mietzner T.A. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 49 (2005) 316-322
32. Blondelle S.E., and Lohner K. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. Biopolymers 55 (2000) 74-87
33. Fernandez-Lopez S., Kim H.S., Choi E.C., Delgado M., Granja J.R., Khasanov A., Kraehenbuehl K., Long G., Weinberger D.A., Wilcoxen K.M., et al. Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature 412 (2001) 452-455
34. Epand R.M., and Epand R.F. Liposomes as models for antimicrobial peptides. Methods Enzymol. 372 (2003) 124-133
35. Stephens O.M., Kim S., Welch B.D., Hodsdon M.E., Kay M.S., and Schepartz A. Inhibiting HIV fusion with a β-peptide foldamer. J. Am. Chem. Soc. 127 (2005) 13126-13127
36. Kritzer J.A., Stephens O.M., Guarracino D.A., Reznik S.K., and Schepartz A. β-Peptides as inhibitors of protein-protein interactions. Bioorg. Med. Chem. 13 (2005) 11-16
37. Kritzer J.A., Lear J.D., Hodsdon M.E., and Schepartz A. Helical β-peptide inhibitors of the p53-hDM2 interaction. J. Am. Chem. Soc. 126 (2004) 9468-9469
38. Tang H., Doerksen R.J., and Tew G.N. Synthesis of urea oligomers and their antibacterial activity. Chem. Commun. (2005) 1537-1539
39. Tew G.N., Liu D., Chen B., Doerksen R.J., Kaplan J., Carroll P.J., Klein M.L., and DeGrado W.F. De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci. USA 99 (2002) 5110-5114